AdvanSix (ASIX) & Its Rivals Critical Analysis

AdvanSix (NYSE: ASIX) is one of 46 publicly-traded companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its competitors? We will compare AdvanSix to similar businesses based on the strength of its earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.

Earnings and Valuation

This table compares AdvanSix and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AdvanSix $1.19 billion $34.14 million 27.01
AdvanSix Competitors $1.91 billion $115.75 million 182.01

AdvanSix’s competitors have higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent recommendations and price targets for AdvanSix and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdvanSix 0 0 1 0 3.00
AdvanSix Competitors 172 944 1237 24 2.47

AdvanSix currently has a consensus target price of $46.00, suggesting a potential upside of 7.78%. As a group, “Specialty Chemicals” companies have a potential upside of 1.68%. Given AdvanSix’s stronger consensus rating and higher possible upside, research analysts clearly believe AdvanSix is more favorable than its competitors.

Volatility & Risk

AdvanSix has a beta of 2.84, suggesting that its share price is 184% more volatile than the S&P 500. Comparatively, AdvanSix’s competitors have a beta of 1.37, suggesting that their average share price is 37% more volatile than the S&P 500.

Profitability

This table compares AdvanSix and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdvanSix 3.64% 20.30% 5.64%
AdvanSix Competitors -673.55% -5.10% -0.12%

Institutional and Insider Ownership

71.3% of AdvanSix shares are held by institutional investors. Comparatively, 65.1% of shares of all “Specialty Chemicals” companies are held by institutional investors. 2.7% of AdvanSix shares are held by company insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

AdvanSix beats its competitors on 8 of the 13 factors compared.

AdvanSix Company Profile

AdvanSix Inc. is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia. The Company offers ammonium sulfate, which is used by customers as a nitrogen-based fertilizer. It produces ammonium sulfate fertilizer as part of its manufacturing process. The Company manufactures ammonium sulfate fertilizers including Sulf-N and Sulf-N 26. The Company provides AdvanSix Aegis nylon resins and Aegis barrier nylon resins. Its nylon resins are a preferred choice in food, liquid, and consumer packaging along with mono/multifilament products, carpet fibers, automotive compounding and more. It offers Capran biaxially oriented nylon films.

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply